Baxter International (BAX) Change in Accured Expenses (2009 - 2026)

Baxter International (BAX) has 18 years of Change in Accured Expenses data on file, last reported at $203.0 million in Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 41.96% year-over-year to $203.0 million in Q1 2026; TTM through Mar 2026 was $209.0 million, a 494.34% increase from a year earlier, with the FY2025 full-year figure at $149.0 million, up 238.64% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $203.0 million, up from $180.0 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for BAX reached as high as $554.0 million in Q4 2023 and fell as low as -$396.0 million in Q4 2022.
• Historically, Change in Accured Expenses has averaged $31.2 million across 5 years, with a median of $8.0 million in 2025.
• Across the five-year window, Change in Accured Expenses slumped 397.06% in 2023 and jumped 301.68% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at -$396.0 million in 2022, then soared by 239.9% to $554.0 million in 2023, then sank by 126.71% to -$148.0 million in 2024, then surged by 221.62% to $180.0 million in 2025, then grew by 12.78% to $203.0 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $203.0 million in Q1 2026, $180.0 million in Q4 2025, and -$182.0 million in Q3 2025.